
View larger version (95K):
[in a new window]
|
Fig. 4. Effects of suppression of Cs-FGF4/6/9 function with a specific antisense morpholino oligo on the expression of (A,A') epidermis-specific gene Cs-Epi1, (B,B') endoderm-specific histochemical activity of alkaline phosphatase, (C,C',D,D') muscle-specific actin gene Cs-MA1, (E,E',F,F') notochord-specific Cs-Bra, (G,G',H,H') notochord-specific gene Cs-fibrn, (I,I',I'') mesenchyme-specific gene Cs-mech1, and nervous system-specific genes (J,J') Cs-otx and (K,K') Cs-ETR. Arrows in D' indicate extra cells with Cs-MA1 expression. The black arrow in E' indicates no Cs-Bra expression in the left-side notochord cells while the white arrow points to Cs-Bra expression in the right-side notochord cells. This embryo developed from the 2-cell stage in which the left-side blastomere was injected with morpholino oligo. Two embryos in the insert were developed from eggs injected with morpholino oligo, and they do not show the expression of Cs-Bra. (I'') Recovery of expression of Cs-fibrn in tailbud embryos developed from eggs injected with Cs-FGF4/6/9 morpholino oligo together with in-vitro-synthesized Cs-FGF4/6/9 mRNA.
|